RecruitingPriority 4 · Lower priorityNCT04087629
StrataCTX® as a Steroid Sparing Device
Plain-language summary
This is a research study collecting clinical information and/or biological samples from patients with cutaneous T-cell lymphoma (CTCL), including mycosis fungoides or Sézary syndrome at various stages of their disease to advance understanding of these diseases and improve future treatments. No experimental treatment is given as part of this study. This trial is available at 1 location in the United States.
Who can join (key eligibility)
- Age 18 Years or older
- See full trial listing for complete eligibility
Final eligibility is determined by the trial team. This list is a starting point only.
What's being tested
StrataCTX® gel (DEVICE): Gel forming flexible wound dressing for the prevention and treatment of radiation dermatitis
StrataCTX® gel
- Treatment length
- Ask the trial team for details
- Visit frequency
- Ask the trial team for details